Immunization with biodegradable nanoparticles efficiently induces cellular immunity and protects against influenza virus infection

Journal of Immunology

Volumn 190, Issue 12, 2013, Pages 6221-6229

  Knuschke, Torben ^a   Sokolova, Viktoriya ^b   Rotan, Olga ^b   Wadwa, Munisch ^a   Tenbusch, Matthias ^c   Hansen, Wiebke ^a   Staeheli, Peter ^d   Epple, Matthias ^b   Buer, Jan ^a   Westendorf, Astrid M ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM PHOSPHATE; GAMMA INTERFERON; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIODEGRADABILITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFICACY; EFFECTOR CELL; EX VIVO STUDY; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA A (H1N1); INFLUENZA VACCINATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTECTION; VIRAL CLEARANCE; VIRUS IMMUNITY;

ADMINISTRATION, INTRANASAL; ANIMALS; CALCIUM PHOSPHATES; FLOW CYTOMETRY; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; IMMUNITY, CELLULAR; INFLUENZA VACCINES; INJECTIONS, INTRAPERITONEAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; NANOPARTICLES; T-LYMPHOCYTES; VACCINATION;

EID: 84879093054     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202654     Document Type: Article

References (35)

1. Sallusto, F., A. Lanzavecchia, K. Araki, and R. Ahmed. 2010. From vaccines to memory and back. Immunity 33: 451-463.
2. Zinkernagel, R. M. 2002. Immunity, immunopathology and vaccines against HIV? Vaccine 20: 1913-1917. (Pubitemid 34450786)
3. Bråve, A., K. Ljungberg, B. Wahren, and M. A. Liu. 2007. Vaccine delivery methods using viral vectors. Mol. Pharm. 4: 18-32.
4. Flatz, L., A. N. Hegazy, A. Bergthaler, A. Verschoor, C. Claus, M. Fernandez, L. Gattinoni, S. Johnson, F. Kreppel, S. Kochanek, et al. 2010. Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity. Nat. Med. 16: 339-345.
5. Haglund, K., I. Leiner, K. Kerksiek, L. Buonocore, E. Pamer, and J. K. Rose. 2002. Robust recall and long-term memory T-cell responses induced by prime-boost regimens with heterologous live viral vectors expressing human immunodeficiency virus type 1 Gag and Env proteins. J. Virol. 76: 7506-7517. (Pubitemid 34760973)
6. Hubbell, J. A. 2010. Drug development: Longer-lived proteins. Nature 467: 1051-1052.
7. Chen, K., and A. Cerutti. 2010. Vaccination strategies to promote mucosal antibody responses. Immunity 33: 479-491.
8. Nembrini, C., A. Stano, K. Y. Dane, M. Ballester, A. J. van der Vlies, B. J. Marsland, M. A. Swartz, and J. A. Hubbell. 2011. Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination. Proc. Natl. Acad. Sci. U. S. A. 108: E989-E997.
9. Ichinohe, T., A. Iwasaki, and H. Hasegawa. 2008. Innate sensors of influenza virus: clues to developing better intranasal vaccines. Expert Rev. Vaccines 7: 1435-1445.
10. Perrone, L. A., A. Ahmad, V. Veguilla, X. Lu, G. Smith, J. M. Katz, P. Pushko, and T. M. Tumpey. 2009. Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge. J. Virol. 83: 5726-5734.
11. Wee, J. L., J. P. Scheerlinck, K. J. Snibson, S. Edwards, M. Pearse, C. Quinn, and P. Sutton. 2008. Pulmonary delivery of ISCOMATRIX influenza vaccine induces both systemic and mucosal immunity with antigen dose sparing. Mucosal Immunol. 1: 489-496.
12. Bachelder, E. M., T. T. Beaudette, K. E. Broaders, J. M. Fréchet, M. T. Albrecht, A. J. Mateczun, K. M. Ainslie, J. T. Pesce, and A. M. Keane-Myers. 2010. In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants. Mol. Pharm. 7: 826-835.
13. Tai, W., L. Roberts, A. Seryshev, J. M. Gubatan, C. S. Bland, R. Zabriskie, S. Kulkarni, L. Soong, I. Mbawuike, B. Gilbert, et al. 2011. Multistrain influenza protection induced by a nanoparticulate mucosal immunotherapeutic. Mucosal Immunol. 4: 197-207.
14. Demento, S. L., N. Bonafé, W. Cui, S. M. Kaech, M. J. Caplan, E. Fikrig, M. Ledizet, and T. M. Fahmy. 2010. TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis. J. Immunol. 185: 2989-2997.
15. Sokolova, V., T. Knuschke, J. Buer, A. M. Westendorf, and M. Epple. 2011. Quantitative determination of the composition of multi-shell calcium phosphate-oligonucleotide nanoparticles and their application for the activation of dendritic cells. Acta Biomater. 7: 4029-4036.
16. Sokolova, V., T. Knuschke, A. Kovtun, J. Buer, M. Epple, and A. M. Westendorf. 2010. The use of calcium phosphate nanoparticles encapsulating Toll-like receptor ligands and the antigen hemagglutinin to induce dendritic cell maturation and T cell activation. Biomaterials 31: 5627-5633.
17. Kirberg, J., A. Baron, S. Jakob, A. Rolink, K. Karjalainen, and H. von Boehmer. 1994. Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor. J. Exp. Med. 180: 25-34. (Pubitemid 24181052)
18. Morgan, D. J., R. Liblau, B. Scott, S. Fleck, H. O. McDevitt, N. Sarvetnick, D. Lo, and L. A. Sherman. 1996. CD8(+) T cell-mediated spontaneous diabetes in neonatal mice. J. Immunol. 157: 978-983.
19. Fouchier, R. A., T. M. Bestebroer, S. Herfst, L. Van Der Kemp, G. F. Rimmelzwaan, and A. D. Osterhaus. 2000. Detection of influenza Aviruses from different species by PCR amplification of conserved sequences in the matrix gene. J. Clin. Microbiol. 38: 4096-4101. (Pubitemid 32233210)
20. Hart, D. N. 1997. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 90: 3245-3287. (Pubitemid 27473395)
21. Choy, J. H., S. Y. Kwak, Y. J. Jeong, and J. S. Park. 2000. Inorganic Layered Double Hydroxides as Nonviral Vectors This work was in part supported by the Korean Ministry of Science and Technology through the NRL project and by the Korean Ministry of Education (BSRI-99-3413). S.Y.K. expresses her thanks to the BK21 fellowship. Angew. Chem. Int. Ed. Engl. 39: 4041-4045.
22. Macatonia, S. E., N. A. Hosken, M. Litton, P. Vieira, C. S. Hsieh, J. A. Culpepper, M. Wysocka, G. Trinchieri, K. M. Murphy, and A. O'Garra. 1995. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J. Immunol. 154: 5071-5079.
23. Belser, J. A., X. Lu, T. R. Maines, C. Smith, Y. Li, R. O. Donis, J. M. Katz, and T. M. Tumpey. 2007. Pathogenesis of avian influenza (H7) virus infection in mice and ferrets: enhanced virulence of Eurasian H7N7 viruses isolated from humans. J. Virol. 81: 11139-11147. (Pubitemid 47536086)
24. Belser, J. A., D. A. Wadford, C. Pappas, K. M. Gustin, T. R. Maines, M. B. Pearce, H. Zeng, D. E. Swayne, M. Pantin-Jackwood, J. M. Katz, and T. M. Tumpey. 2010. Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice. J. Virol. 84: 4194-4203.
25. Fahmy, T. M., S. L. Demento, M. J. Caplan, I. Mellman, and W. M. Saltzman. 2008. Design opportunities for actively targeted nanoparticle vaccines. Nanomedicine (Lond) 3: 343-355. (Pubitemid 351827311)
26. Liu, J., Z. Jiang, S. Zhang, C. Liu, R. A. Gross, T. R. Kyriakides, and W. M. Saltzman. 2011. Biodegradation, biocompatibility, and drug delivery in poly (ω-pentadecalactone-co-p-dioxanone) copolyesters. Biomaterials 32: 6646-6654.
27. Lo, C. T., P. R. Van Tassel, and W. M. Saltzman. 2010. Poly(lactide-coglycolide) nanoparticle assembly for highly efficient delivery of potent therapeutic agents from medical devices. Biomaterials 31: 3631-3642.
28. Kohlmeier, J. E., and D. L. Woodland. 2009. Immunity to respiratory viruses. Annu. Rev. Immunol. 27: 61-82.
29. Lambrecht, B. N., and H. Hammad. 2009. Biology of lung dendritic cells at the origin of asthma. Immunity 31: 412-424.
30. Neumann, S., A. Kovtun, I. D. Dietzel, M. Epple, and R. Heumann. 2009. The use of size-defined DNA-functionalized calcium phosphate nanoparticles to minimise intracellular calcium disturbance during transfection. Biomaterials 30: 6794-6802.
31. Klinman, D. M., S. Klaschik, T. Sato, and D. Tross. 2009. CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases. Adv. Drug Deliv. Rev. 61: 248-255.
32. Krishnamachari, Y., and A. K. Salem. 2009. Innovative strategies for co-delivering antigens and CpG oligonucleotides. Adv. Drug Deliv. Rev. 61: 205-217.
33. Sun, J., R. Madan, C. L. Karp, and T. J. Braciale. 2009. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat. Med. 15: 277-284.
34. Herremans, T. M., J. H. Reimerink, A. M. Buisman, T. G. Kimman, and M. P. Koopmans. 1999. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus. J. Immunol. 162: 5011-5018. (Pubitemid 29314910)
35. Neutra, M. R., and P. A. Kozlowski. 2006. Mucosal vaccines: the promise and the challenge. Nat. Rev. Immunol. 6: 148-158. (Pubitemid 43361590)